14 February 2025
Latham & Watkins Advises atai Life Sciences on Public Offering of Common Shares
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | capital markets | New York |
| Kaj Nielsen | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Katie Byun | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Adam Picker | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Skye Lee | Latham & Watkins LLP | Associate | capital markets | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 2.10 (US$2.10 per share)
- What the figure measures
- Per share
- Client
- atai Life SciencesIssuer
- Counterparties
- Not stated